Sue - Interview 47  

Sue - Interview 47

Age at Interview: 68
Sex: Female
Age at Diagnosis: 66
Background: Sue is married and she has two grown-up children. She is a retired secretary. Ethnic background/nationality: White British.

Brief outline:Sue was diagnosed with lung cancer in 2008. She had 4 cycles of chemotherapy, which was effective, but had bad side effects. When the tumour grew again in 2009 she started a biological therapy, erlotinib (Tarceva) with good results, and is still having it.

More about me...

To watch or read an interview clip, click on the heading that interests you. Either a video,audio recording or text will open, depending on the clip
To close transcript boxes, click here
To print the interview’s text, click here
Female
Sue is aware that her treatment may cost the NHS a great deal of money because she will be taking it for as long as it is effective.

 



What’s your view in general about the National Health Service after all this treatment that you’ve had?
 
I think that it, it needs to be funded in a different way. This is just my personal view. I don’t see how the National Health Service can go on doing what it needs to do out of general taxation. I really think there should be some different way of funding it. And I don’t know how that would work. Possibly something like the French system, although I don’t think that doesn’t seem to be, I mean people always quote it, don’t they? but it does struggle, even so. I think, I really think possibly something like some kind of insurance that people pay, instead of the way it’s done now with the health service being allocated what can be spared at the time out of general taxation. That’s the way it seems to work now, isn’t it?
 
Have you come to that view because you’ve felt sometimes there was a shortage of staff?
 
No, I’ve always felt that. I think that as time, as time goes on and more and more wonderful drugs are available, and people are going to live longer and be treated for things for longer, and more and more of them, I just cannot see how the health service can go on with the system of funding that it has and be expected to do what it’s expected to do. I just think it needs a lot more. And I don’t think it can just be, I don’t see how it can work under the present system.
 
Have you any idea how much Tarceva costs?
 
Yes, it’s approximately £1600 for a thirty day supply. It is very expensive.
 
Yes, like many other chemotherapy drugs.
 
Yes, yes, indeed. And, but the thing with Tarceva is that it’s not a limited period of treatment. For as long as it works, I’ll be taking it. And as long as, well, my, as long as I, as the side effects don’t become unbearable and as long as the treatment is working, I’ll be taking it. So, you know, nobody knows how long that will be.
 
It’s given you quite good quality of life, hasn’t it?
 
Yes, it really has. Yes, I’m very grateful for it, very grateful for it, yes.

Karol Sikora - Lung cancer
   Support our work

Mail to a friend

Send